輸入代號或公司名稱後按 Enter
4142

國光生

-0.30 (-1.71%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
17.20769成交張數本益比1.57股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.38-0.34-1.60-240.0%-3.42%-3.06%
2026Q1-0.44-0.48-1.86-225.4%-3.83%-4.14%
2025Q40.52-0.572.2029.6%4.56%-4.71%
2025Q3-0.04-106.3%-1.21-0.18-3.8%-0.39%-10.15%
2025Q2-0.52-0.54-2.19-201.4%-4.48%-4.64%
2025Q1-0.53-0.67-2.23-309.6%-4.36%-5.47%
2024Q4-0.12-0.58-0.48-8.9%-0.92%-4.53%
2024Q30.631.6%-1.442.6329.6%5.10%-10.88%
2024Q2-0.65-1.45-2.74-343.1%-5.30%-11.38%
2024Q1-0.44-1.37-1.84-419.3%-3.41%-10.28%
2023Q4-0.98-800.0%-1.52-4.14-74.0%-7.28%-11.03%
2023Q30.62-36.7%-0.402.6427.1%4.57%-2.73%
2023Q2-0.57-618.2%-0.04-2.41-291.6%-4.17%-0.16%
2023Q1-0.590.64-2.49-146.7%-4.15%4.69%
2022Q40.14-79.7%0.680.6110.4%0.98%4.74%
2022Q30.98164.9%1.234.2038.6%6.96%8.66%
2022Q20.110.620.458.6%0.77%4.52%
2022Q1-0.550.13-2.35-444.4%-3.89%0.97%
2021Q40.69-77.2%0.102.9537.2%4.90%0.69%
2021Q30.37-9.8%2.441.6121.4%2.71%18.10%
2021Q2-0.382.48-1.63-185.2%-2.70%18.46%
2021Q1-0.582.50-2.50-3604.6%-4.03%19.00%
2020Q43.033.0312.40151.0%21.84%24.92%
2020Q30.41-25.4%-0.021.6026.0%3.28%-0.48%
2020Q2-0.360.12-1.43-226.2%-3.08%-1.71%
2020Q1-0.05-0.12-0.17-4.6%-0.41%-3.36%
2019Q4-0.02-0.90-0.22-3.5%-0.60%-10.62%
2019Q30.55-2.271.1121.8%3.05%-21.71%
2019Q2-0.60-2.85-1.72-163.6%-6.87%-26.38%
2019Q1-0.83-2.55-1.97-327.3%-12.77%-36.71%
2018Q4-1.39-2.44-3.48-85.7%-19.61%-32.46%
2018Q3-0.03-2.26-0.06-1.9%-0.31%-25.97%
2018Q2-0.30-2.68-0.77-252.8%-3.95%-29.97%
2018Q1-0.72-2.97-1.78-252.8%-8.68%-31.71%
2017Q4-1.21-3.05-3.03-143.6%-13.36%-30.48%
2017Q3-0.45-2.69-1.12-49.5%-4.49%-24.41%
2017Q2-0.59-2.76-1.49-297.8%-5.67%-23.92%
2017Q1-0.79-2.59-1.96-259.8%-7.03%-21.54%
2016Q4-0.86-2.39-2.13-71.9%-7.18%
2016Q3-0.52-1.29-83.8%-4.13%